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INTRODUCTION
Esophageal cancer is the sixth most common fatal cancer in the world. The five 
year  survival  rate is  among the lowest  for  all  cases (14%)1 ,  the main reason being 
cancer  of  the  esophagus  becomes  symptomatic  at  an  advanced  phase  with  a  late 
diagnosis, when the tumor is already incurable. Most of these cases come to clinical 
attention after they have spread beyond the esophagus and become inoperable.
           The only way to prevent this is by early detection of esophageal malignancies. 
For  this  ,the  susceptible  population  should  be  subjected  to  some  type  of  screening 
programme to identify any precancerous conditions. Squamous dysplasia and squamous 
cell carcinoma in situ are the two major categories  which are thought to be precursor 
lesions  of  frank  esophageal  malignancy.   All  grades  of  squamous  dysplasia  and 
carcinoma  in  situ are  associated  with  a  significantly  increased  risk  of  developing 
esophageal squamous cell carcinoma. Increasing grades of dysplasia are associated with 
dramatically increased risk. If these dysplastic lesions can be identified in the high risk 
population, this dreadful condition can be dealt with more effectively. 
There is well documented epidemiologic studies linking tobacco and alcohol use 
with  the  development  of  esophageal  cancer.  Alcohol  was  estimated  to  be  causally 
associated with approximately 80% of esophageal cancers and the relative risk increases 
with  the amount of alcohol consumed. Likewise, the risk associated with tobacco use 
appears to increase with the  number of cigarettes smoked per day, duration of smoking 
and  tar  content.  Ex-smokers  have  reduced  risk  compared  to  current  smokers.  A 
synergistic effect for the combined habit of alcohol use and smoking or tobacco chewing 
has been reported. It is likely that  these agents may also have a causal role in dysplasia 
of esophagus.
By  studying  this  high  risk  group  for  the  development  of  dysplasia,  a  causal 
association  can  be  established,  which  can  be  used  as  a  basis  for  devising  effective 
screening protocols to pick up cases at an early stage.  Once dysplasia is documented, it 
can be classified as mild, moderate or severe based on the extent to which the immature 
cells replace the normal epithelium. Mild dysplasia might be reevaluated periodically or 
treated  by  chemoprevention.  Moderate  dysplasia  may  be  followed  more  closely  or 
treated by focal endoscopic therapy. Severe dysplasia and carcinoma in situ should be 
treated by endoscopic mucosal resection which is a  therapeutic method based on the 
principle of strip biopsy for resection of flat lesions of gastro intestinal tract which  helps 
to prevent these lesions from progressing to inoperable stage.
           With changing social habits, more and more people are becoming habituated to 
the use of alcohol and tobacco, which makes this kind of screening programme all the 
more mandatory. Hence an attempt has been made here to establish a causal association 
between these risk factors and development of dysplasia. The high risk group has been 
defined as individuals with habits like alcohol consumption, smoking, tobacco chewing 
and intake of hot beverages like coffee and tea  either alone or in combination who are 
more prone to develop dysplasia.
Esophageal biopsies of asymptomatic individuals who belong to high risk group 
are examined for the presence of dysplasia, comparing the findings with age matched 
subjects  without  the  risk  factors.  Correlation  of  duration  of  risk    factors  and  the 
occurrence  of dysplasia  is also  evaluated.
Further the significance of AgNOR study in dysplasia of the esophagus  is also 
evaluated.  Various studies in different organs have proved that  AgNOR numbers are 
increased  in  malignant  cells  compared  to  corresponding  benign  or  normal  cells. 
Moreover interphase AgNOR numbers are closely related to the proliferative activity of 
cells.  The AgNOR numbers in quiescent cells is generally low while in proliferating 
cells such as cancer cells, a high AgNOR number is present.
AgNOR staining  and  counting  of  AgNOR numbers  is  done  to  determine  any 
increase in AgNOR numbers in dysplastic esophagus compared to normal esophagus, 
thereby evaluating the degree of proliferative activity in dysplastic cells.   Dysplastic 
cases are further subdivided into mild, moderate and severe and the variation in AgNOR 
numbers is also analysed, which could help in determining the prognostic significance of 
these lesions.
It is an attempt to find out the presence of dysplasia in asymptomatic individuals 
belonging to the high risk group and evaluate the significance of the  role of risk factors 
in causation, which can be used for prevention research and also for early detection of 
cases by specific protocols  in susceptible population  thereby reducing the morbidity 
and mortality associated with this dreadful disease.
AIMS AND OBJECTIVES
1. Study  of  prevalence  of  dysplasia  in  the  middle  third  of  esophagus  in 
asymptomatic  individuals  with  high  risk  factors  like  alcohol  consumption, 
smoking and tobacco chewing and comparing it  with  individuals without  these 
risk factors.
2.  Grading of esophageal dysplasia into mild, moderate and severe dysplasia on the 
basis of the thickness of the epithelium showing  dysplastic  changes.
3. AgNOR staining  of  the  biopsy  material  and  evaluation  of  AgNOR score   in 
different grades of dysplasia and its comparison with the normal esophagus  and 
malignancy.
4. To  assess  the  usefulness  of  AgNOR  study  as  a  proliferation  marker   and 
prognostic indicator.
REVIEW OF LITERATURE
Squamous cell carcinoma is the most common malignant tumor of the esophagus 
and it is one of the most common fatal cancers worldwide. Especially high risk areas 
have been identified in Northern Iran, Central  Asian Republics,  Northern China and 
South Africa.  In some of these areas over 20% of the population die  of  esophageal 
cancer. It is the sixth most common fatal cancer in the world, the five year survival rate 
among the lowest for all cancers (14%)1. The main reason for this poor prognosis is that 
most  cases  are  asymptomatic   and  go  undetected  until  they  have  spread  beyond 
esophagus and are unresectable.
In sharp contrast to the rest of the gastro intestinal tract, the esophagus is mostly 
devoid of a serosal coat. Only a small segment of the intra abdominal esophagus  is 
covered by serosa. The  thoracic  esophagus  is surrounded by fascia that condenses 
around the esophagus to form a sheath like structure. The intimate anatomic proximity to 
important thoracic viscera, the great vessels and the tracheo bronchial tree are significant 
factors in facilitating the early and widespread dissemination of esophageal malignancy 
into the posterior mediastinum. The rich network of mucosal and submucosal lymphatics 
that run longitudinally along the esophagus further facilitate the tumor spread 2.
Early diagnosis has been shown to improve the survival rate. Therefore successful 
strategies for  primary prevention and early detection of curable lesions are critically 
required.   If  precursor  stage  of  this  malignancy  can  be  identified  by  screening  the 
susceptible population, it will avoid a great deal of morbidity and mortality associated 
with this dreadful disease.3 
Esophagitis, atrophy and dysplasia may be precursor lesions of esophageal cancer 
in high risk population. Increasing grades of dysplasia are associated with increased risk. 
Severe dysplasia and carcinoma in situ have similar degrees of risk.4            
Esophageal  squamous dysplasia can be graded histologically depending on the 
thickness  of  epithelial  involvement.  Risk  of  developing  invasive  squamous  cell 
carcinoma is  closely  correlated  to  the  severity  of  esophageal  dysplasia  encountered. 
Correct recognition of esophageal dysplasia  is thus important.5
Histological categories that can be encountered in a esophageal biopsy specimen 
include the following:1
Normal
 A stratified squamous epithelium which shows no features  diagnostic of other 
histological categories. Mature squamous cells with abundant clear cytoplasm, scattered 
lymphocytes and compressed nuclear fragments are occasionally seen in the epithelium. 
The lamina propria contains few scattered mononuclear inflammatory cells.
Acanthosis 
An otherwise normal epithelium which is more than 0.5 mm thick.  
Esophagitis
One or more of the following three criteria: 
• Elongation of lamina propria papillae into upper third of epithelium with basal 
cell hyperplasia more than 15% of total epithelial thickness.
• Epithelial infiltration by neutrophils or eosinophils. 
• A  dense  non  follicular  infiltrate  of  mononuclear  inflammatory  cells  or 
neutrophils in the lamina propria.
Basal cell hyperplasia
An otherwise normal epithelium has a basal zone thickness of more than 15% 
total  epithelial  thickness,  without  elongation  of  lamina  propria  papillae  or  other 
abnormality.
Squamous dysplasia
Nuclear atypia (enlargement, pleomorphism and hyperchromasia), loss of normal 
cell polarity and abnormal tissue maturation present in
the lower one third of the epithelium - mild dysplasia
lower two thirds of the epithelium - moderate dysplasia 
In full thickness of the epithelium  - severe dysplasia.
Squamous dysplasia (NOS)
Dysplastic biopsies which can not be graded because of biopsy size or orientation 
are graded as squamous dysplasia  (NOS) – Not otherwise specified.
Squamous cell carcinoma in situ (CIS)
Dysplasia of squamous cells involving the full thickness of the epithelium without 
invasion and with intact basement membrane.
Squamous cell carcinoma
Neoplastic  squamous  cells  are  present  which   have  invaded   through  the 
basement membrane.
Grading  of  increased  expansion  in  the  basal   layer,  as  the  proliferating  cells 
progress from normal to hyperplasia to dysplasia  and to carcinoma can be  done. The 
hyperplastic  and dysplastic cells  are fundamental phase of carcinomatous change in the 
esophageal mucosa. It shows a wide spectrum of cellular alterations in the course of 
malignant change and the close relationship between the morphological alterations and 
cell  biology.6  With  quantitative  morphometry  it  is  possible  to  differentiate  normal 
squamous epithelium from dysplastic carcinoma in situ in esophagus. The epithelium is 
divided  into  3  zones.Nuclear  density,  nuclear  area,  nuclear  irregularity  and  nuclear 
ovality are the morphological variables.  Nuclear area in the superficial zone, nuclear 
perpendicularity in the intermediate zone, nuclear density in the total epithelial thickness 
and interzonal variation of these variables are helpful in this differentiation.7
Continuity  of  dysplastic  lesions  into   the  areas  of  carcinoma  is   more  often 
encountered in severe dysplasia, which suggests some relationship between the severity 
of dysplasia and carcinoma.8
 Dysplasia is considered to be the earliest malignancy of  the esophagus based on 
such biologic features as the histopathological features, proliferative activity and altered 
expression of cancer associated genes. It therefore becomes essential to detect and treat 
these lesions endoscopically .9
Usha  et al in their clinicopathologic study of carcinoma of the esophagus with 
reference  to  changes  in  the  surrounding  epithelium  have  found  that  dysplasia  was 
present in all cases of carcinoma esophagus. 70% of the tumors were squamous cell 
carcinomas.10
                  Takiyama et al have observed that squamous dysplastic lesion is commonly 
associated with carcinoma of the esophagus. Squamous cell carcinoma of the esophagus 
develops from severe dysplasia in a similar manner to carcinoma of cervix. 11
                  Ohta et al have studied the distribution of esophageal dysplasia in cancer of 
esophagus and a possible relationship of epithelial dysplasia to the origin of esophageal 
cancer which was shown by at least 2/3 of esophageal cancers.12
The wide geographic and cultural variations in the incidence of squamous cell carcinoma of the 
esophagus suggest that environmental exposure is causally important.  Numerous epidemiologic studies 
have linked alcohol and tobacco use with the development of esophageal cancer. Ethanol was estimated 
to be causally associated with approximately 80% of the neoplasms and the relative risk increases with 
the amount of alcohol consumed. The association with esophageal cancer is strongest with liquor, 
intermediate with wine and weakest with beer. Since there is an inverse relationship between the 
caloric intake of alcohol and a wholesome diet, alcohol may increase the risk of esophageal cancer by 
reducing nutrient intake. The risks associated with tobacco use appear to increase with number of 
cigarettes smoked per day, duration of smoking and tar content. 13
Ex smokers have a reduced risk compared to current smokers. A synergistic effect for the 
combined habit of alcohol drinking and tobacco smoking or chewing has been reported .
Squamous cell carcinoma of the esophagus becomes symptomatic at a late stage 
when  the  disease  is  already  advanced,and  this  contributes  to  its  poor  prognosis. 
Endoscopy of asymptomatic individuals exposed to known risk factors associated with 
the  development  of  this  cancer  may  facilitate  the  diagnosis  of  early  cancers  or 
precancerous lesions. 
           Esophageal squamous cell carcinoma has been reported to be epidemiologically 
associated with tobacco and alcohol consumption.14 Individuals who abuse alcohol and 
smoke have a high prevalence of dysplastic lesions.15 Gao  et al in their study for risk 
factors for esophageal cancer have found that risk of esophageal cancer was increased 
among  tobacco  smokers  and  alcohol  drinkers.  Risk  is  increased  with  number  of 
cigarettes smoked per day, duration of smoking, number of pack years and decreasing 
age at start of smoking. The combined effect of heavy smoking and drinking among men 
is  more  pronounced.  Cigarette  smoking  and  alcohol  drinking  combined  account  for 
almost 50% of esophageal cancers.16
Vaugen et al have come to the conclusion that an extraordinary high proportion of 
the excessive risk for esophageal cancer can be attributed to alcohol drinking.17 Use of 
alcohol  and  tobacco  are  significant  risk  factors  for  squamous  cell  carcinoma  of 
esophagus.  Lu and Lion in their study of risk factors of esophageal cancer have come to 
the  conclusion  that  cigarette  smoking  and  alcohol  drinking  are  risk  factors  for 
esophageal cancer.18
Takiyama et al studied the relationship between dysplasia and the consumption of 
alcohol and tobacco and have come to the conclusion that in some manner alcohol and 
tobacco consumption appear to increase the susceptibility of the squamous mucosa to 
malignant transformation.19
Takiyama et al in their clinicopathological study of dysplasia in human esophagus 
have  observed that  the incidence  of  dysplasia  was  frequent  in  men than in  women. 
Carcinoma in situ and severe dysplasia were more frequent where there was a history of 
habitual  drinking  and  smoking.  Predisposing  factors  for  high  grade  dysplasia  of 
esophagus are gender, smoking and drinking.20
Saeki  et al studied the biologic and clinical significance of squamous epithelial 
dysplasia  of  esophagus and  consider  dysplasia  to be the earliest  malignancy of  the 
esophagus. The relation of alcohol consumption and cigarette smoking to the multiple 
occurrence of esophageal dysplasia  and squamous cell carcinoma21 was observed by 
them.
Rotthawns et al in their article about prevention of esophageal cancer have said 
that smoking and alcohol are the major risk factors for squamous cell carcinoma. The 
prognosis is poor with 5 yr survival of less than 10%. Only early stages have a good 
prognosis. Prevention of squamous cell carcinoma can be done by avoiding drinking and 
smoking.22 
Mascres and colleagues studied the morphological changes of esophageal mucosa 
in  rats.  15 litter  matched pairs  of  rats  were divided into 2 groups.  One was fed on 
alcoholic diet and the other was fed on isocaloric diet .Basal cell pleomorphism and 
tendency  towards  epithelial  dysplasia  were  observed  after  long  time  alcohol 
consumption in the first group.23
AgNOR  STUDY
Nucleolar  organiser  regions  (NORs)  are  defined  as  nucleolar  components 
containing  a  set  of  argyrophilic  proteins,  which  are  selectively  stained   by  silver 
methods.  After  silver-staining,  the  NORs  can  be  easily  identified  as  black  dots 
exclusively  localised  throughout  the  nucleolar  area,  and  are  called  “AgNORs”.  The 
NORs’ argyrophilia is due to a group of nucleolar proteins, which have a high affinity 
for silver (AgNOR  proteins).                                
AgNOR proteins accumulate in highly proliferating cells whereas their expression 
is very low in non-proliferating cells. Some of these proteins remain associated with the 
nucleolar organizer regions (NORs) during mitosis.  In situ, the expression of AgNOR 
proteins  is  measured  globally  by  quantification  of  the  level  of  silver  staining  using 
morphometry  and  image  analysis.  To  go  deeper  into  the  understanding  of  the 
relationship  between the cell cycle and quantity of AgNOR proteins, it is necessary  to 
determine the phases of cell cycle during which expression of AgNOR varies and what 
are the most variable proteins in each phase. The amount of AgNOR   proteins can be a 
marker  of  proliferation,  because  this  amount  is  related  to  cell  cycle  phases, 
schematically low for G1 phase and high for S-G2 phase. Thus, it is a measure of the 
relative proportion of cells in each phase, and consequently of the timing of each phase. 
The higher value indicates that the major part of the cells are in the S-G2 phase and 
correlatively few are in the G1 phase, and this characterizes a rapid cell cycle.24 
Interphase AgNORs are structural-functional units of the nucleolus in  which all 
the components necessary for ribosomal RNA synthesis are located. Two argyrophilic 
proteins involved in rRNA transcription and processing, nucleolin and nucleophosmin, 
are associated with interphase AgNORs and are responsible for their stainability with 
silver methods, thus allowing interphase AgNORs to be visulaized at light microscopic 
level,  also  in  routine  cyto-histopathological  preparations.  The  number  of  interphase 
AgNORs  is  strictly  related  to  rRNA  transcriptional  activity  and,  in  continuously 
proliferating cells, to the rapidity of cell proliferation. 
The  quantity  of  interphase  AgNORs,  evaluated  by  morphometric  analysis, 
increases in   cycling cells from early G1-phase to the late S-phase. In cancer tissues, the 
AgNOR value is also closely related to both the percentage of cycling cells (measured 
by Ki67 or PCNA immunolabelling) and S-phase cells. Data from cell lines cultured in 
vitro have clearly shown that  interphase AgNOR quantity is related to cell  doubling 
time,  the  faster  the  rapidity  of  cell  proliferation,  the  greater  the  interphase  AgNOR 
quantity.25
SepLeek  RD,  has  observed  variations  in  the  occurrence  of  silver-staining 
nucleolar organizer regions (AgNORs) in non-proliferating and proliferating cells. An 
increase in the size of AgNOR clusters rather than their number correlated positively 
with elevated labelling, particularly with  the emergence of silver-staining regions of 2-3 
microns visible  diameter.26
AgNORs in normal cells are usually aggregated tightly within one or two nucleoli 
evident in histological or cytological preparations and individual AgNORs are often not 
discernible.The number of detectable AgNORs depends on several factors.27 
1. The level of transcriptional activity.
2. The number of NOR bearing chromosomes in the karyotype. 
3. The stage of the cell cycle.
Thus  there  is  a  striking  discrepancy  between  AgNOR counts  in  chromosome 
spreads  and  those  reportedly  observed  in  histological  sections  of  similar  cell 
preparations.Histopathologists rarely record  more than one or two AgNOR dots per 
nucleus in benign cells.This is due to the difficulty in perceiving the individual AgNORs 
when they are seen within a relatively small nucleus.
In malignancy,the AgNORs become dispersed through the nucleus to a varying 
extent,enabling the histopathologist to count them easily. The quantification of AgNOR 
interphase nuclei is related to their dispersion through the nucleoplasm than to the actual 
numbers present. Hence, the histologic AgNOR count in benign and malignant lesions 
denotes the numerical index of AgNOR dispersion rather than the absolute number of 
AgNORs.
Quantitative analysis of AgNOR proteins is a reliable marker of the rapidity of 
cell duplication and a significant prognostic parameter in tumour pathology. The rate at 
which a tumour proliferates represents an important parameter for predicting the clinical 
outcome of patients with neoplastic diseases. Rapidly growing tumours are expected to 
have a worse behaviour than slowly proliferating ones, and there is increasing evidence 
that  high  growth-rate  cancers  require  aggressive  treatment  for  better  control  of  the 
disease. Cell kinetics data are, therefore, useful for pathologists and clinical oncologists 
in order to obtain valuable prognostic information and to define the most appropriate 
therapeutic  strategy in  single  cases.  Over  the past  20 years,  several  methods of  cell 
proliferation  assessment  have  been  developed  and  employed  in  routine  pathology. 
Among these, the quantitative analysis of AgNOR  proteins has recently been proposed 
as a reliable indicator of the rapidity of cell duplication.28 
Over  the  past  12  years,  the  “AgNOR  method”  has  been  applied  in  tumour 
pathology for both diagnostic and prognostic  purposes. In order to achieve definitive 
standardisation of the AgNOR method and produce comparable data in all laboratories, 
the “International Committee on AgNOR Quantitation” was founded, and during  the 
first Workshop “AgNORs in Oncology” held in Berlin in 1993 guidelines for AgNOR 
protein evaluation were first defined.29
Techniques for demonstration of NORs 
 The most popular method among all in locating the NORs is the silver staining 
technique.  The  structures  demonstrated  by  this  method  are  called  AgNORs 
(Argyrophilic  Nucleolar  organizing Regions).  The silver  staining  technique does  not 
identify  rRNA or  rDNA,  but  the  acidic  NORAPs  associated  with  the  site  of  RNA 
transcription.  The  silver  staining technique is  based  on the principle  that,  the  acidic 
NORAPs have a high affinity for silver salts as a result of their high electron density and 
by virtue of their phosphate ,carboxyl and sulphur moieties.
The Argyrophil technique
The principle advantages of the AgNOR technique are the relative simplicity of 
the staining method and the ease of application to archival tissues. The one step method 
consists  of  mixing  silver  nitrate  and  formic  acid  with  gelatin  acting  as  a  colloid 
stabilizer. Paraffin embedded or frozen sections or cytological smears are incubated in 
this mixture for variable periods of time and then washed and mounted.
The silver reaction product is seen as discrete black dots at the light microscopic 
level which can be measured using oil immersion objective.Counting of AgNOR dots is 
done  in  a  minimum of  100 cells  and the  results  expressed  as  the  mean  number  of 
AgNORs  per  nucleus.  With  minor  modifications,  this  technique  can  be  used  in 
semiautomatic and fully automated image analysers30 where the total amount of AgNOR 
material per nucleus rather than the number of dots counted.
Tissue fixation and processing
The intensity of AgNOR staining is dependant on the fixative used, and the results 
vary accordingly. Alcohol based fixatives, especially Carnoy’s fixative gives optimal 
results. Mercurial and Dichromate fixatives are highly detrimental to AgNOR staining.31 
10% neutral buffered formalin gives optimal staining comparable to alcohol fixatives.
An important factor to be standardized in this technique is the thickness of the 
sections.  The  ideal  standard  is  a  moderately  thick  section  which  contains  all  NOR 
profiles and at the same time, thin enough where NORs can be readily separated.32
AgNOR staining reaction
            Usually the AgNOR staining reaction is run for 60 minutes irrespective of the 
type of tissue.However some minor alterations are recommended according to internal 
controls to allow subsidiary of AgNOR dots.
Non specific background silver grain deposits are a usual problem which can be 
minimized by the use of scrupulously clean glassware and double distilled water.
The minor modifications suggested are:
1. Pre incubation in glycine prior to AgNOR staining which reduces background 
staining by blocking the free or  reversibly bound aldehyde residues left  by 
formalin fixation.
2. Use  of  polyethylene  glycol  as  a  protective  colloidal  developer  in  place  of 
gelatin.33
3. Use of 10% nitric acid on the slides after completion of the staining procedure. 
4. Use of inverted incubation technique, wherein the slides are inverted in the 
staining  solution,  which  maintains  a  high  degree  of  contrast  between  the 
background and the AgNORs.34 
Enumeration of AgNORs
Three  main  types  of  AgNOR  configuration  can  be  described  in  normal  or 
neoplastic  cells.  The  NORs  can  aggregate  to  form  a  solitary  rounded  argyrophilic 
structure called as AgNORs corresponding to the nucleolus per se. Individual NORs 
cannot be resolved within the nucleus.
The second configuration is called the ‘Nucleolar pattern’, which is often seen in 
proliferating  cells.  The  NORs can  be  seen  within  the  nucleolus  with  careful  use  of 
AgNOR  technique.  Finally  the  true  AgNORs  may  be  dispersed  through  the 
nucleoplasm. This pattern is frequently observed in malignant cells. These features are 
demonstrated especially well in cytological preparations, but can be seen in carefully 
prepared paraffin sections.
There are  two methods of counting AgNORs:
1. All silver stained structures could be counted, but when seen in groups, each 
cluster is counted as one structure.
2. When AgNORs can be seen separately within a nucleolus, each AgNOR can 
be counted as  a  single  unit,  together  with small  AgNORs seen outside the 
nucleolus. 
If the AgNOR count represents nucleolar disaggregation, which in turn reflects 
cellular activity, it is important to assess if AgNORs can be resolved within nucleoli. 
Meticulous attention should be paid in such cases to technique and reaction timing.
AgNOR count (mAgNOR) – Mean AgNORs/ nucleus.
AgNOR proliferative index (p AgNOR) – Percentage of cells exhibiting five or 
more AgNORs / nucleus.
The mAgNOR represents the mean DNA content of the cells or ploidy whereas 
pAgNOR represents the S- phase fraction.35
AgNOR score
Each AgNOR dot is classified as small, medium and large according to its size. A 
small dot is defined as a just visible but distinct one, when seen under the oil immersion 
objective. Dots about three times the size of a small one are classified as medium and 
those about five times or more the size of a small dots are classified as large.
The AgNOR score is calculated by multiplying the number of small dots by a 
factor of one, medium dots by a factor of three, and the number of large dots by a factor 
of five and adding up the three.
Improvements in the AgNOR technique
Ploton  first  described  the  Argyrophilic  staining  technique  in  1986.  Several 
modifications of the technique have been designed since then, aimed at improving the 
overall staining reaction as well as to enhance the information that is obtained. Some of 
the modifications include the following: 
1. Sequential demonstration of Nucleolar Organizer regions and various antigens 
in  both  paraffin  and frozen  sections:  This  method is  of  great  value  in  the 
evaluation  of  AgNOR  numbers  in  neoplasms  where  cell  populations  are 
heterogenous.  Immunostaining  for  proliferative  markers  demarcate  the  cell 
populations  accurately  prior  to  AgNOR  counting.  Combining 
immunocytochemistry  and  AgNOR  staining  on  a  single  preparation  gives 
positive  results  on  fixed  tissue  with  immuno  alkaline  phophatase  methods 
providing  better  contrast.  Trypsinisation  of  the  sections  prior  to 
immunostaining does not alter the count of silver stained granules.
2. Combination of a modified AgNOR staining technique with Feulgen reaction: 
This  technique  not  only  enables  the  counting  of  active  NORs but  also  the 
evaluation of the amount of DNA in the nucleus.
3. Combination of cyto fluorometric analysis with conventional silver staining of 
NORs on cell suspensions: This AgNOR – FCM technique can be applied to 
analyze clinicopathological samples including neoplastic tissues more quickly 
and quantitatively than regular staining with AgNORs.
4. Use of  AgNOR technique with minor  modifications  in  semi-automatic  and 
automatic image analysis hardware: This method enables the measurement of 
the total amount of Argyrophilic material per nucleus instead of counting the 
number of AgNOR sites.36 Moreover, the incorporation of automated image 
analysis hardware in the technique makes it less subjective than the traditional 
methods.
5. Pretreatment with 7% nitric acid: This method gives very distinct dark brown 
images  of  AgNORs  on  a  yellow background.  The  gradient  of  background 
colors  allow  easy  discrimination  of  nucleolar,  nuclear  and  cytoplasmic 
structures. Many morphometric parameters related to number, size and shape 
of AgNORs can be evaluated quantitatively by image analysis on  sections 
pretreated with nitric acid and on adjacent sections treated with citrate buffer 
in a wet autoclave according to the most widely accepted method for image 
analysis of AgNOR. Both methods give similar results. A second improvement 
is achieved by coating the slides with 7% celloidin solution in ethyl alcohol-
ether prior to AgNOR staining and acid pretreatment. This coating prevents 
nonspecific silver deposition on argyrophilic bacteria and other tissue debris in 
human vaginal smears that could make visualizing AgNOR sites difficult. 
6. Finally,  placing  sections  face  down  on  the  staining  solution  prevents  the 
formation of nonspecific silver precipitates. These procedures can be applied 
together  or  separately  according  to  the  requirements  of  the  material  to  be 
evaluated.37
7. Quantitation  of  AgNORs  by  flow  versus  image  cytometry:  AgNORs  are 
nucleolar proteins that interact specifically with silver salts. The size of silver 
precipitates measured by image analysis (ICM) in cycling cells proved to be 
inversely  proportional  to  the  cell  cycle  time  and  provided  a  significant 
correlation with prognosis for a large spectrum of cancers.  Because ICM is 
time-consuming and poorly reproducible  among laboratories  using different 
imaging settings,  a  new approach to AgNOR quantitation is based on flow 
cytometry (FCM). Silver precipitates caused a great decrease in the forward 
scattered light and that this effect was correlated with the AgNOR's relative 
area as measured by ICM. These results were confirmed by measuring cell 
lines having different  cell  cycle durations.  Moreover,  double  staining using 
APase-Fast red fluorescence to reveal the Ki-67/MIB 1 antigen of cycling cells 
and silver nitrate to stain the AgNORs was successfully analyzed by FCM. 
This  procedure makes  it  possible,  for  the first  time,  to  validly  and rapidly 
compare the growth fraction and cycling speed of partially proliferating cell 
populations, such as tumors.38 
A  revised  version  of  the  AgNOR  staining  technique  involves  the  use  of 
microwave radiation in order to shorten the processing time,  the use of gelatin as a 
protective colloid, and a Farmer's solution to optimize the specificity of the technique 
giving highly contrasting AgNORs with minimal  unspecific silver  precipitation,  thus 
facilitating both manual and computerized counting.39 
Yekeler H has described a sensitive staining method for NORs instead of silver 
staining. As NORs are loops of DNA which are transcribed into ribosomal RNA, they 
can be demonstrated by staining with silver nitrate, since NOR-associated proteins are 
argyrophilic,  producing  structures  termed  AgNORs.  The  number  and  resolution  of 
NORs  increased  2-3  times  by  blue  toning  (30mmol/l  FeCl3,  11  mmol/l  potassium 
hexacyanoferrate(III), and 33 mmol/l oxalic acid) compared  with silver  staining.
A significant  difference  in  the  number  of  NORs was  noticed  between  silver- 
stained and blue-toned cells (P<0.001). The blue toning   technique thus appears to be 
more sensitive in detecting NORs than the AgNOR method and may prove a useful 
alternative for applications in histopathology.40
Applications of the AgNOR technique
The AgNOR technique was first applied in histopatholgy  in prostatic     tissue. 
Since  then  numerous  studies  have  been  performed  in  a  variety  of  tissues  for  both 
malignant and non-malignant conditions.
Nucleolar  organizer  region  staining  patterns  in  paraffin-embedded  tissue, 
increased  number  of  nucleoli  (nucleolar  organizer  regions,  NORs)  with    abnormal 
shapes and sizes, including small dots, has been used as prognostic tools to evaluate 
tumor proliferation levels and troublesome borderline lesions. All types of cancer cells 
show variable  numbers  of  abnormally  shaped  nucleoli  and dot-like  structures.  Only 
tumor cells presented four or more nucleoli,  with or without dots,  while 85% of the 
normal cells have one single NOR without dots. Changes in the number and shape of 
nucleoli  present  in  malignant  cells  could  be  attributed  to  increased  levels  of  rDNA 
transcription on cancer cells, besides abnormal remodeling of chromatin, which could 
disrupt proper nucleoli association.41
Prognostic significance of argyrophilic nucleolar organizer regions   (AgNOR) in 
oesophageal cancer: AgNOR  has been shown in recent  times, to have value in knowing 
the prognosis of carcinoma oesophagus. Since the AgNOR counting is a simple method 
and can be applied to paraffin embedded sections, estimation of the AgNOR number 
may  help  in  determination  of  prognosis  in  patients  with  oesophageal  carcinoma. 
Preoperative radiotherapy  seems to  decrease AgNOR count with improved survival.42
Also the number of argyrophilic nucleolar organizer regions is a good indicator of 
lymph  node  metastasis  in  patients  with  esophageal  carcinoma.  The  number  of 
argyrophilic  nucleolar  organizer  regions (AgNORs)  were evaluated as a predictor  of 
lymph node metastasis in  patients who underwent resection of advanced squamous cell 
carcinoma of the  esophagus. Results indicated that the AgNOR score is a good indicator 
of lymph node metastasis and suggest that it might also be a useful prognostic marker in 
patients with esophageal cancer.43
AgNORs can also be used as predictors of post operative distant recurrences in 
esophageal carcinoma. Pathologic factors and the number of nucleolar organizer region 
proteins (AgNORs) were evaluated as predictors of  post operative recurrence in  distant 
organs in  patients with curatively resected esophageal carcinoma. Findings indicated 
that the combination of venous invasion and a high AgNOR score predicts distant post 
operative  recurrences in patients with curatively resected esophageal carcinoma.44 
Prognostic significance of argyrophilic nucleolar organizer regions in esophageal 
carcinoma was studied by Morita M, and the AgNOR number was   found to be one of 
the  independent  and  significant  variables  (P<0.01).  Because  the  AgNOR method  is 
simple  and can  be  applied  to  paraffin-embedded sections,  the AgNOR number  may 
provide potential benefit in the pretherapeutic assessment of malignant potentiality in 
esophageal carcinoma.45 
Remmerbach,  in  his  study  of  diagnostic  value  of  nucleolar  organizer  regions 
(AgNORs) found that the best cut-off value of the mean number of AgNOR dots per 
nucleus, distinguishing benign from malignant cells was 4.8. The percentage of nuclei 
with more than three AgNORs had a cut-off level of 70%. Applying these methods to 
doubtful  or  suspicious  cytological  diagnoses,  he  was  able  to  correctly  establish  the 
diagnosis  of  malignancy  in  histologically  proven  cases.  AgNOR-analysis  may  be  a 
useful adjunct to other methods in routine cytological diagnosis of cancer that can help 
to solve cytologically suspicious or doubtful cases.46 
Prathiba studied the value of AgNORs in premalignant and malignant lesions of 
the cervix and observed that statistically significant difference in AgNOR counts was 
noted in different  sets  of  lesions and state  that  this  technique can serve as  a useful 
adjunct to routine histopathology. Study of the argyrophilic nucleolar organizer regions 
(AgNORs), which was used extensively in cytogenetics, has been identified as a reliable 
indicator of cell proliferation and in turn, the malignant potential of a lesion.47
Xie evaluated the diagnostic and prognostic value of nucleolar organizer regions 
in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity and 
concluded that AgNOR enumeration, in particular pAgNOR > 1, appears to be a useful 
tool  in  distinguishing  between  normal  epithelium,  dysplasia,  and  squamous  cell 
carcinoma  of  the  oral  cavity.  In  this  study,  AgNOR counts  were  strong  prognostic 
markers for patients with squamous cell carcinoma.48  Pelusi in his study observed that 
AgNOR protein quantity of cervical smears correlates with that of histological sections 
in cervical intraepithelial neoplasia. AgNOR protein quantity of cervical smears actually 
reflects  that  of  the  cervical  epithelium  in  situ and  may  therefore  be  useful  for  the 
cytological diagnosis of cervical lesions.49
Xu  in  his  study  on  morphological  typing  of  argyrophilic  nucleolar  organizer 
regions has observed that the diffuse type (78%) was the most frequently seen, and in 
benign lesions, the nucleolar type (92.85%); The difference was thus highly significant 
(P<0.001). The intranucleolar and aggregate types were not observed in benign lesions. 
There was no obvious difference in the proportion of the mixed type in benign and 
malignant lesions (P>0.05).50  
Progressive  increase  in  AgNOR counts  was  observed  by  Misra  JS,  when  the 
severity  of  pathologic  lesions  increased.  Statistical  analysis  revealed  a  significant 
difference  in  AgNOR counts  between  normal  and  inflammatory  smears,  but  it  was 
highly significant between inflammatory and LSIL cases, between  Low grade squamous 
intraepithelial lesions (LSIL) and High grade squamous intraepithelial lesions (HSIL), 
and between severe dysplasia and frank malignancy. This underscores the diagnostic 
importance of AgNOR counts, especially in discriminating between LSIL and HSIL of 
the cervix.51 
A morphometric study of nucleolar organiser regions in cervical intraepithelial 
neoplasia by Terlikowski showed that the number increases with CIN level when the 
cells contain 4  and more AgNORs. The number of granules per 100 cells also increases 
with the degree of CIN. It indicates that the number of cells with 4 and more AgNOR 
granules can serve as a CIN differentiation exponent.52 
Pahuja  in  his  study  of  proliferative  activity  in  squamous  intraepithelial  and 
invasive  lesions  aimed  at  assessing  the  proliferation  in  preinvasive  and  invasive 
squamous  epithelial  lesions  of  cervix  using  a  simple  and  inexpensive  proliferation 
marker observed that  highest  mean of AgNORs per  nucleus was observed in poorly 
differentiated squamous cell carcinoma of cervix. He concluded that AgNORs can prove 
to be a simple, inexpensive and reliable proliferation marker in lesions of cervix.53
Kaushik studied AgNOR counts in cervical lesions. The mean AgNOR counts in 
cervical  epithelium showed  a  progressive  and  statistically  significant  increase  from 
normal to  chronic cervicitis to CIN I, II and III (P<0.001). Scores in carcinoma also 
exceeded that of CIN (P<0.05). This can be a useful adjunct to routine histopathology to 
evaluate cervical lesions.54
PCNA immunostaining combined with AgNOR staining in esophageal squamous 
cell  carcinoma to identify  patients  with a  poor prognosis  was done.  In this  analysis 
PCNA  staining  was  combined  with  an  analysis  of  argyrophilic  nucleolar  organizer 
region  (AgNOR)  staining,  and  a  correlation  with  prognosis  was  found.  The  results 
indicated that this combined evaluation may be useful for the identification of patients 
with a poor prognosis among those undergoing surgery for esophageal squamous cell 
carcinoma.55 
Pahuja in his study of proliferation in squamous cell carcinoma of cervix did a 
comparative  assessment  by  two  markers.  Study  was  aimed  at  assessing  the  cell 
proliferation  in  various  grades  of  squamous  cell  carcinoma  of  cervix  using  two 
proliferation  markers,  AgNORs  and  
Ki-67. Highest mean number of AgNORs was found in poorly differentiated squamous 
cell carcinoma and statistically significant difference was observed between well and 
poorly  differentiated  SCC  and  between  moderately  and  poorly  differentiated  SCC. 
Highest  mean Ki-67 was seen in poorly differentiated SCC. He observed correlation 
between  histological  grade  and  Ki-67  and  AgNORs  separately  but  no  statistically 
significant  correlation  was  found  between  Ki-67 and AgNOR counts.  AgNORs and 
Ki-67 are both simple and easily performed   techniques. They may prove to be a useful 
adjunct in estimating tumor  proliferation and hence in determining the management 
strategy of the  patients.53
AgNOR COUNTS IN VARIOUS ORGAN DISORDERS
AgNOR studies have been done extensively in various organs disorders .Some of 
the  studies  have  documented  the  following  
results.56-60
I LIVER
Diagnosis Mean ± Std. Dev.
 Normal hepatocytes 1.53 0.21
Alcoholic cirrhosis 1.57 0.06
Post hepatitis cirrhosis 3.65 0.53
Hepatocellular carcinoma 7.94 1.18
II  CERVIX 
Diagnosis Mean ± Std. Dev.
Normal cervix 1.36 0.23
Chronic cervicitis 2.31 0.53
C I N – I 2.56 0.69
C I N – II 4.28 1.08
C I N – III 5.16 1.64
Invasive squamous cell carcinoma 6.40 0.81
III PROSTATE 
Diagnosis Mean ± Std. Dev.
Benign Prostatic Hyperplasia 2.93 0.40
BPH with Chronic Prostatitis 3.84 0.44
Prostatic adenocarcinoma
Grade I
Grade II
Grade III
4.98
7.26
10.98
0.72
0.76
1.64
IV  GALL  BLADDER                
Diagnosis Mean ± Std. Dev.
Chronic cholecystitis 1.89  0.96
Epithelial hyperplasia 3.99 1.03
Adenocarcinoma 7.65 1.32
V SOFT TISSUE TUMORS 
Category Mean ±  Std. Dev.
Benign tumors group 1.51 0.21
Fibroma 1.7 0.11
Benign fibrous histicytoma 1.80 0.13
Lipoma 1.21 0.06
Leiomyoma 1.94 0.31
Haemangioma 1.79 0.12
Neurofibroma / Neurilemmoma 1.47 0.03
Malignant tumors group 4.96 1.33
Fibrosarcoma 1.70 0.11
Malignant fibrous histiocytoma 1.80 0.13
Rhabdomyosarcoma 1.21 0.06
Liposarcoma 3.12 0.58
Haemangiopericytoma 6.3 0.87
Metaplastic malignant lesions 6.46 0.92
Round cell tumor(sarcomas) 6.83 1.0
Alveolar soft  part sarcoma 2.44 0.73
MATERIALS AND METHODS
121  Consecutive  male  patients  above  25  years  of  age  who  attended  the 
Department of Medical Gastro Enterology, Govt. Stanley Medical College and Hospital 
for upper GI endoscopy with complaints of dyspepsia without alarm   between July 2004 
and May 2006 constituted  the  study  group.  The  study  was  undertaken  after  getting 
clearance from Ethical committee. Adequate material for study was obtained only in 79 
cases as the rest were found to be either too tiny for processing or inadequate for study.
Information  obtained  included  demographic  data,  occupation,  literacy,  socio 
economic status and habits like smoking, alcohol use, tobacco chewing, use of nasal 
snuff  and use of beverages like hot tea or coffee  and were noted in a pre-structured 
proforma and recorded by a single person. Endoscopic biopsy specimens were obtained 
from the anterior and posterior wall of the middle third of the esophagus. The biopsy 
material was fixed in formalin and the sections of 3-5 microns were obtained and were 
stained  with  routine  Heamatoxylin  and  Eosin  staining  method.  Necessary  micro 
photographs were taken.
Stained sections were studied for the presence or absence of dysplasia and the 
dysplastic cases were further graded into mild, moderate, and severe dysplasia, based on 
the thickness of the dysplastic epithelium and the results were recorded. Any bias in 
reporting was avoided by blinding procedure.
Based on the histopathological report, cases and controls were segregated. 
A  case  was  defined  as  one  with  dysplasia  on  histopathology 
irrespective of risk factors.
A control was defined as one with no dysplasia on histopathology 
irrespective of the risk factors.
After studying the H&E stained sections, a further study was done to assess the 
proliferative activity of the dysplastic cells by staining the sections with silver staining 
procedure. The silver staining for Nucleolar organizing regions was done using silver 
impregnation method and the AgNOR count was done by manual counting using oil 
immersion objective and the results were tabulated    
AgNOR STAINING METHOD
1. Paraffin sections of 3-5 micron thickness were cut.
2. Sections were dewaxed in xylene.
3. Sections were immersed in distilled water.
4. Sections were then layered with 50% silver  nitrate in 2% gelatin-
formic acid solution and incubated in a dark room for 40 minutes at room 
temperature.
5. Sections  were  washed  in  distilled  water,  dehydrated,  cleared  and 
mounted with DPX. 
Slides were studied under oil immersion objective and intranuclear silver stained 
dots were manually counted. Total of 100 cells were studied in each section and AgNOR 
score (mean number of AgNOR dots per nucleus) was calculated and the results were 
tabulated.
The  results  of  H&E  study  and  AgNOR  study  were  tabulated  and  analysed 
statistically. Odds Ratio which indicates the strength of association between risk factors 
and outcome was calculated for each risk factor using standard statistical formulas and 
the results were analysed.
RESULTS
Endoscopic biopsies obtained from the middle third of esophagus from the study 
group  were  stained  with  Haematoxylin  and  Eosin  staining  and  examined  for  the 
presence of dysplasia
Out of 79 biopsies studied, dysplastic changes of varying degrees were found in 
40 biopsies and 39 were reported as  normal. Dysplastic cases were further subtyped into 
mild,  moderate  and  severe  dysplasia  depending  on  the  thickness  of  the  epithelium 
showing dysplastic changes.
Total number of biopsies studied : 79
Biopsies showing dysplasia         : 40
Biopsies reported as normal       : 39 
Mild dysplasia                            : 21
Moderate dysplasia                    : 12
Severe dysplasia                           : 7
The study group was divided into cases and controls based on the results of the 
histopathological examination.
Cases were defined as the group of individuals exhibiting dysplastic changes in 
esophageal biopsy  with or without exposure to the risk factors  under study namely 
alcohol, smoking, other tobacco products and beverages.
Controls were defined as the group of individuals who do not have dysplasia of 
the esophagus irrespective of the presence or absence of exposure to risk factors.
All cases and controls were analysed statistically for different variables and the 
following results were observed.
Number of cases exposed to risk factors:
           Alcohol – 28
           Smoking – 28
Alcohol and Smoking – 23
Other tobacco products – 9
Beverages – 28
Number of controls exposed to risk factors:
Alcohol – 4
Smoking – 8
Alcohol and Smoking – 3
Other tobacco products – 9
Beverages – 34
Mean age of Cases :44.64 ±  9.65
Mean age of Controls : 43.35 ± 9.70 
In each category of exposure, mean age is as follows:
MEAN AGE IN CASES
Risk factor Mean Age
Alcohol 44.10  ±  9.63
Smoking 46.35 ± 10.13
Other tobacco products 44.00 ± 10.6
Beverages 44.20 ± 9.73
MEAN AGE IN CONTROLS
Risk factor Mean Age
Alcohol 41.20 ± 7.45
Smoking 38.75 ± 8.27
Other tobacco products 39.80 ± 9.50
Beverages 42.40 ± 9.32
Odds ratio (Cross-Product ratio) which is defined as the measure of the strength of 
association between risk factors and outcome was calculated in each category with the 
following formula: 
           Odds Ratio  =   ad  /  bc
    a - Number of subjects with exposure and disease
b- Number of subjects with exposure and  without disease
c- Number of subjects with out exposure and  with disease
d- Number of subjects with out exposure and  without disease
ODDS RATIO IN DIFFERENT RISK FACTORS
Risk factor Odds Ratio
Alcohol 22.90
Smoking 10.10
Alcohol and smoking 17. 7
Other tobacco products 1.03
Beverages 0.45
From this data it is very clear that the strength of association is very significant for 
alcohol and smoking as individual factors and also in combination. The association with 
beverages and other tobacco products was not significant as the Odds Ratio was found to 
be  less  
than 2.
Further,  the  risk  factors  were  analysed  for  the  duration  of  exposure.  In  each 
category the number of patients showing dysplasia and the duration of exposure to each 
risk factor was analysed and an attempt was made to ascertain if prolonged exposure has 
any significant increase in the occurrence of more number of dysplasias. Sub categories 
in each risk factor were also analysed.
ALCOHOL
Dysplasia   (28)                                                  No  Dysplasia (4)
Type of spirit Dysplasia No dysplasia
High spirit   26 4
Toddy / Beer   2 0
Both 0 0
Correlation of duration of exposure with dysplasia
Duration of exposure Dysplasia % of cases
< 5 years 5 17.5%
6-10 years 11 39.2%
>10 years 12 42.9%
Among  the  alcohol  users  when  the  duration  was  more  than  
5  years,  risk  was  found  to  be  39.2%  and  with  duration  of  more  than  
10 years the risk was found to be 42.9%.
SMOKING
Dysplasia   (28)                                                  No  Dysplasia (8)
Type of smoke Dysplasia No dysplasia
Cigarettes 10 2
Beedi 9 4
Both 9 2
Correlation of duration of exposure with  dysplasia
Duration of exposure Dysplasias % of cases
< 5 years 5 17.8 %
6-10 years 10 35.7 %
>10 years 13 46.4 %
In smokers, when the duration was more than 5 years, risk was found to be 35.5 % 
and with duration of  more than 10 years  the risk was found to be 46.4 %.
OTHER TOBACCO PRODUCTS
Dysplasia   (9)                                            No  Dysplasia (9)     
Type of tobacco Dysplasia No dysplasia
Snuff 2 2
Beetel nut  7 6
Both 0 1
Correlation of duration of exposure with  dysplasia
Duration of exposure Dysplasia % of cases
< 5 years 5 55.5 %
6-10 years 3 33.3 %
>10 years 1 11.1 %
BEVERAGES
Dysplasia   (28)                                            No  Dysplasia (34)      
Type of beverage Dysplasia No dysplasia
Coffee 10 8
Tea 18 24
Both 0 2
Correlation of duration of exposure with  dysplasia
Duration of exposure Dysplasia % of cases
< 5 years 4 14.2 %
6-10 years 7 25 %
>10 years 17 60.7 %
 
                                  
RESULTS OF AgNOR STUDY
All  the  sections  were  stained  with  silver  staining  technique  and  number  of 
AgNOR dots were counted using oil immersion objective .The results were analysed 
and compared with AgNOR counts of  histopathologically proven esophageal squamous 
cell carcinomas.
The results of AgNOR study are as follows:
HPE  report Number of cases Mean ± Std. Dev.
Normal 29 2.28 ± 0.76
Mild dysplasia 18 2.43 ± 0.39
Moderate dysplasia 15 3.0073 ± 0.63
Severe dysplasia 6 3.4885 ± 0.84
Malignancy 8 4.65 ± 0.47
AgNOR counts were found to increase with the level  of  dysplasia   indicating 
increased proliferation in dysplasia and malignancy.
DISCUSSION
In India, Squamous cell carcinoma of the esophagus is the third most common 
malignancy in men and fourth most common malignancy in women. In men, majority of 
the cases occur in the 6th  and 7th decades. It is commonly seen in lower socio economic 
group and is more prevalent in those who smoke, drink alcohol and use pan or tobacco. 
There  is  an  increase  in  the  incidence  of  malignancies  of  2.8  and  2.5  fold,  seen  in 
smokers  and  tobacco  chewers  respectively.  The  risk  with  alcohol  is  found  to  be 
increased three fold, which is significantly higher than that was reported earlier from 
other  centers  in  our  country.  A  strong  association  is  found  between  cancer  of  the 
esophagus and risk factors like alcohol, smoking and betel nut chewing among South 
Indian patients.
An attempt was made here to ascertain the association of these risk factors to the 
development  of  dysplasia  in  the  middle  third  of  the  esophagus,  the  segment  where 
carcinoma of the esophagus frequently occurs.60 The study attempted to establish if there 
is an increased risk of dysplasia in individuals with these risk factors (High risk group) 
compared to individuals without these habits  (Low risk group).
On analyzing the results it was found that the high risk group is more prone to 
develop dysplasia of the esophagus compared to the low risk group without these risk 
factors.
           When the risk factors were analysed individually as well as in combination, 
smoking and alcohol were found to have a significant association with development of 
dysplasia. This finding correlates with  the previous studies implicating smoking and 
alcohol in the causation of squamous cell carcinoma of the esophagus. Thus  the aim of 
trying  to  establish  smoking  and  alcohol  as  high  risk  factors  associated  with  the 
development of dysplasia is achieved with the results of this study, and can be a strong 
indicator of the susceptible population which should be subjected to vigorous screening 
programmes to detect early lesions. 
When the dysplastic cases were studied for subtyping into mild, moderate and 
severe dysplasia it was observed that in the same case different areas showed different 
grades of dysplasia and this is a clear indication of the natural progression of increasing 
grades of dysplasia similar to other dysplasia - carcinoma sequences like carcinoma of 
the cervix. This is a very strong point which argues in favour of the need for routine 
screening protocols as being practiced for carcinoma of the cervix. This could lead to 
early intervention which may help to abort these lesions from progressing unchecked to 
inoperable advanced malignancy.
Some of the individuals showed dysplastic changes without history of exposure to 
any of the risk factors included in this study. It implies that there could be other agents 
or  risk  factors  responsible  for  the  development  of  dysplasia  in  such  cases  and  it 
underscores the need for more such studies to unravel the unknown culprits.
 The  study  of  AgNORs  has  recently  received  increased  attention  because  of 
claims that  the frequency within the nuclei  is  significantly  higher in malignant  cells 
compared to normal, reactive or benign cells indicating highly increased proliferative 
activity in malignancies. Counting of AgNORs gives a score which is representative of 
the level of proliferative activity of the sample studied. While evaluating AgNOR study, 
various parameters like mAgNOR, and AgNOR score are done.
Hence,  AgNOR  staining  was  done  in  dysplastic  cases  as  well  as  normal 
epithelium in this study to evaluate the number of AgNOR dots and  to document the 
degree of proliferative activity in dysplastic lesions and the results were compared with 
normal  esophageal  epithelium.  It  was  also  attempted  to  establish   if  there  is   any 
variation in the number of AgNOR dots in the different grades of dysplasia. Most of the 
cells  showed  well  delineated  NORs with  irregular  morphology  dispersed  within  the 
nucleoplasm.
It was found that AgNOR counts are of definite value in grading of dysplasia and 
when  considered  along  with  other  proliferation  markers  it  could  be  of  even  more 
significance.The application of AgNOR as a potential prognostic indicator or predictor 
of optimal treatment protocol may require long term clinical follow up.
AgNOR can be combined with other prolifeative markers as PCNA, Ki67, or P53 
which  are  other  cell  cycle  associated  proteins.  Since  increase  in  the  AgNOR count 
implies  increased  proliferative  activity  which  is  a  fertile  soil  for  development  of 
malignancy,  those  with  increased  AgNOR  count  should  be  considered  as  potential 
candidates for developing malignancy and these individuals should have frequent follow 
up. 
The increase in the proliferative activity of the cells can be evaluated and the 
association  between  various  grades  of  dysplasia  and  the  development  of  overt 
malignancy can be documented by regular follow-up study of these individuals who can 
be considered for endoscopic mucosal resection if there is any indication of progression. 
On histopathological examination of the esophageal biopsies the dysplastic cases 
were sub typed into mild, moderate and severe and AgNOR count was done in all these 
categories and results were noted.
HPE  report Number of cases Mean ± Std. Dev.
Normal 29 2.28 ± 0.76
Mild dysplasia 18 2.43 ± 0.39
Moderate dysplasia 15 3.0073 ± 0.63
Severe dysplasia 6 3.4885 ± 0.84
Malignancy 8 4.65 ± 0.47
It was observed that the difference in AgNOR values in normal epithelium and 
dysplasia is very significant and the AgNOR values in malignant epithelium was very 
much increased compared to  normal  epithelium. However  when the values for  mild 
moderate  and  severe  dysplasias   were  compared  as  separate  groups,  the  difference 
between  normal  epithelium and  mild  dysplasia  was  not  marked.  But  moderate  and 
severe  dysplasia  showed  significant  difference  in  values  as  compared  to  normal 
epithelium. Since mild dysplasia is not considered as a potential premalignant lesion 
compared  to  moderate  and  severe  dysplasia  this  observation  in  mAgNOR  is 
understandable.
The marked difference between mAgNOR of normal epithelium and malignant 
epithelium signifies the value of AgNORs as a proliferative marker and its utility in 
dysplasia as a screening tool.  When it is used in combination with other proliferative 
markers  it  will  definitely  give  very  significant  information  about  the  malignant  or 
premalignant potential of the sample studied.  Specifically it can be applied to organs 
like cervix, esophagus, skin  etc.,  where dysplasia has been proved  as premalignant 
condition.
AgNOR study similar  to the present  study has been done in cases of cervical 
dysplasia which showed the following values.
Category Mean  ± Std. Dev.
 Normal Cervix 1.36 ± 0.23
Chronic cervicitis 2.31 ± 0.53
C I N - I 2.56 ± 0.69
C I N - II 4.28 ± 1.08
C I N - III 5.16 ± 1.64
Invasive squamous cell carcinoma  6.40 ± 0.81
In this AgNOR  study  the following values were observed: 
Category Mean ± Std. Dev
Normal esophagus 2.28 ± 0.76
Mild dysplasia 2.43 ± 0.39
Moderate dysplasia 3.0073 ± 0.63
Severe dysplasia 3.488 ± 0.84
Malignancy 4.65 ± 0.47
The AgNOR  values observed in  the study of esophageal dysplasia and the values 
observed in the study of cervical dysplasia are more or less similar,whereas the values in 
other organ system lesions  were not comparable with this study, indicating that different 
organ systems may have different AgNOR counts in dysplasia as well as in malignant 
lesions. It could also underline the lack of standardization in AgNOR study and inter 
observer variations and the need for elimination of these shortcomings so as to make 
AgNOR study which is a simple and inexpensive procedure, a valuable proliferation 
marker and prognostic indicator.  
SUMMARY
             
 Study was contemplated to evaluate the risk factors for esophageal dysplasia and 
to assess the correlation between the duration of exposure to the risk factor and the grade 
of dysplasia in the high risk population.
Risk factors included in the study 
Alcohol, Smoking, Other tobacco products and Beverages.
Total number of patients included in the study group : 79
Cases  - Patients who showed dysplasia on H&E examinations: 40
Controls - Number of biopsies which showed no dysplasia : 39
Dysplastic  biopsies  were  further  graded   into  mild,  moderate  and   severe 
dysplasia.
Mild dysplasia :21
Moderate dysplasia :12
Severe dysplasia:7
The results were analysed  statistically and Odds Ratio was calculated for each 
risk factor. The results are summarised  as follows:
Risk factors Cases Controls Odds ratio
Alcohol 28 4 22.9
Smokers 28 8 10.1
Alcohol & smoking 23 3 17.7
Other tobacco users 9 9 1.03
Beverages 28 34 0.45
Alcohol consumption  and risk of dysplasia
Duration of exposure > 5   years  :   39.2 %  
Duration of exposure > 10 years  :   42.9 %
Smoking and risk of dysplasia  
Duration of exposure > 5 years  :  35.5%
Duration of exposure  >10 years :  46.4%
Further the significance of AgNOR study in dysplasia of the esophagus was also 
evaluated.The results were analysed  and compared with AgNOR counts of   normal 
esophageal  epithelium and  esophageal squamous cell carcinoma.
The results of AgNOR study are as follows:
HPE  report Number of cases Mean ± Std. Dev.
Normal 29 2.28 ± 0.76
Mild dysplasia 18 2.43 ± 0.39
Moderate dysplasia 15 3.0073 ± 0.63
Severe dysplasia 6 3.4885 ± 0.84
Malignancy 8 4.65 ± 0.47
CONCLUSION
 Study has attempted at correlation of risk factors and their duration with onset 
of dysplasia in the oesophagus. vailable literature does not show any similar 
studies.
 Alcohol and smoking (either  alone or  in combination),  with a duration  of 
more than 10 years is likely to predispose an individual to dysplasia.
 Conclusions on beverages needs  further validation.
 Dysplasia is more prevalent in the high risk group as compared to low risk 
group.
 Dysplasia in persons in the low risk group may be due  to other  risk factors 
not included in the study (18%).
 AgNOR study  is  a  simple,inexpensive  and  reliable  proliferation  marker  in 
esophageal dysplasia.
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PROFORMA
Study of Dysplasia in Endoscopic Biopsy from 
Esophagus
Sl.No.                      Name:                                 Age:             Sex:
MGE No.
Indication for endoscopy:
Smoker: YES / NO     Duration: ___years    Type:Beedi / Cig/ Others
                                                                       No.per day______
Alcohol:YES / NO      Duration: ___years   Type:Whisky / Rum/ 
   Beer /   Arrack/Others
   Quantity_____    ml/day
Tobacco: YES / NO       Duration: ___ years       No. of times/day:
Snuff:  YES / NO           Duration: ____ years     No. of times/day:
Coffee: YES / NO          Duration: ____years      No. of cups/day:
Tea: YES / NO               Duration: ____ years     No. of cups/day:
Endoscopy findings:
HPE Report:
69

AgNOR STATISTICS
Sl.
No.
Normal Normal
Biopsy No. mAgNOR Biopsy No. mAgNOR
1 E-3 2.94 E-66 1.77
2 E-6 2.06 E-75 2.84
3 E-12 2.13 E-84 2.73
4 E-17 2.89 E-99 2.27
5 E-21 2.18 E-100 3.04
6 E-24 1.78 E-108 3.06
7 E-26 4.19 E-111 1.96
8 E-27 1.65 E-112 2.7
9 E-28 4.33 312 1.76
10 E-30 2.13 712 1.87
11 E-45 2.19 1576 1.65
12 E-52 1.58 1995 1.73
13 E-57 1.02 2093 1.55
14 E-58 2.67 2111 1.56
15 E-63 1.81
Average 2.27724
 ± Std. Dev. 0.76292
73
AgNOR STATISTICS
Sl.
No.
Mild Dysplasia Moderate Dysplasia
Biopsy No. mAgNOR Biopsy No. mAgNOR
1 E-4 2.14 E-10 3.91
2 E-8 3.39 E-14 3.05
3 E-9 2.57 E-23 3.31
4 E-11 2.29 E-35 3.1
5 E-16 2.46 E-38 1.85
6 E-25 2.26 E-40 2.72
7 E-31 2.95 E-44 2.28
8 E-41 2.65 E-46 2.69
9 E-42 2.87 E-47 3.2
10 E-50 2.34 E-71 2.78
11 E-59 2.39 E-76 2.46
12 E-60 1.73 E-77 3.69
13 E-67 2.31 E-78 2.53
14 E-69 1.94 E-102 3.34
15 E-73 2.13 E-104 4.2
16 E-91 2.17
17 E-101 2.8
18 E-110 2.35
Average 2.434705882 3.0073333
± Std. Dev. 0.40584969 0.631545346
74
AgNOR STATISTICS
Sl.
No.
Severe Dysplasia Malignancy
Biopsy No. mAgNOR Biopsy No. mAgNOR
1 E-51 2.48 4470 4.52
2 E-62 3.99 4480 4.24
3 E-74 2.52 350 5.09
4 E-88 2.12 4537 3.84
5 E-92 2.67 351 4.67
6 E-103 3.3 946 5.15
7 ES-1 3.93 183 5.12
8 ES-2 3.47 1099 4.55
9 ES-3 4.12
10 ES-4 3.89
11 ES-5 4.52
12 ES-6 3.48
13 ES-7 4.86
Average 3.48846153
8
4.6475
± Std. Dev. 0.84089 0.46536468
75
